The observation that KMT2A-rearranged leukemias are critically dependent on Menin [27] and more particularly the interaction between Menin and KMT2A [28] has prompted the development of small molecule inhibitors of this protein-protein interaction [51]. Here, MEN1 is linked to leukemia.